Shopping Cart
Remove All
Your shopping cart is currently empty
SJL2-1 is a PRMT5 inhibitor with an IC50 value of 1.56 μM. It suppresses the proliferation, migration, and invasion of prostate cancer cells and induces apoptosis while causing cell cycle arrest at the G0/G1 phase. SJL2-1 targets intracellular PRMT5, inhibiting androgen receptor methylation and expression. It is applicable in research on early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SJL2-1 is a PRMT5 inhibitor with an IC50 value of 1.56 μM. It suppresses the proliferation, migration, and invasion of prostate cancer cells and induces apoptosis while causing cell cycle arrest at the G0/G1 phase. SJL2-1 targets intracellular PRMT5, inhibiting androgen receptor methylation and expression. It is applicable in research on early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer (CRPC). |
| In vitro | SJL2-1 inhibits the proliferation, migration, and invasion of prostate cancer cells (including 22RV1, PC-3, and LNCaP cells) at concentrations of 2.96-60 μM over 24-96 hours. It induces apoptosis and causes cell cycle arrest in the G0/G1 phase in the same cell lines at 15-45 μM over 48 hours. Additionally, SJL2-1 at 15-45 μM reduces the expression of PRMT5, downstream SDMA and SmD3me2S proteins, and decreases androgen receptor levels in 22RV1, PC-3, and LNCaP cells. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.